Knights Of Columbus Asset Advisors LLC Viking Therapeutics, Inc. Transaction History
Knights Of Columbus Asset Advisors LLC
- $1.59 Billion
- Q2 2025
A detailed history of Knights Of Columbus Asset Advisors LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Knights Of Columbus Asset Advisors LLC holds 18,459 shares of VKTX stock, worth $622,991. This represents 0.03% of its overall portfolio holdings.
Number of Shares
18,459
Previous 18,729
1.44%
Holding current value
$622,991
Previous $452,000
8.19%
% of portfolio
0.03%
Previous 0.03%
Shares
9 transactions
Others Institutions Holding VKTX
# of Institutions
448Shares Held
65.3MCall Options Held
8.28MPut Options Held
3.44M-
Vanguard Group Inc Valley Forge, PA10.2MShares$343 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$203 Million0.01% of portfolio
-
State Street Corp Boston, MA4.06MShares$137 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY3.13MShares$106 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.12MShares$105 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.59B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...